These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1702767)

  • 1. Properties of pertussis toxin mutant PT-9K/129G after formaldehyde treatment.
    Nencioni L; Volpini G; Peppoloni S; Bugnoli M; De Magistris T; Marsili I; Rappuoli R
    Infect Immun; 1991 Feb; 59(2):625-30. PubMed ID: 1702767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal and systemic immunogenicity of a recombinant, non-ADP-ribosylating pertussis toxin: effects of formaldehyde treatment.
    Cropley I; Douce G; Roberts M; Chatfield S; Pizza M; Marsili I; Rappuoli R; Dougan G
    Vaccine; 1995 Dec; 13(17):1643-8. PubMed ID: 8719514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The reaction of bacterial toxins with formaldehyde and its use for antigen stabilization.
    Petre J; Pizza M; Nencioni L; Podda A; De Magistris MT; Rappuoli R
    Dev Biol Stand; 1996; 87():125-34. PubMed ID: 8854009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9K/129G, is an effective mucosal adjuvant for intranasally delivered proteins.
    Roberts M; Bacon A; Rappuoli R; Pizza M; Cropley I; Douce G; Dougan G; Marinaro M; McGhee J; Chatfield S
    Infect Immun; 1995 Jun; 63(6):2100-8. PubMed ID: 7768587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetically detoxified pertussis toxin (PT-9K/129G): implications for immunization and vaccines.
    Seubert A; D'Oro U; Scarselli M; Pizza M
    Expert Rev Vaccines; 2014 Oct; 13(10):1191-204. PubMed ID: 25183193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic, humoral, and cellular responses in adult volunteers immunized with the genetically inactivated pertussis toxin mutant PT-9K/129G.
    Podda A; Nencioni L; De Magistris MT; Di Tommaso A; Bossù P; Nuti S; Pileri P; Peppoloni S; Bugnoli M; Ruggiero P
    J Exp Med; 1990 Sep; 172(3):861-8. PubMed ID: 2201750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of formaldehyde, hydrogen peroxide and genetic detoxification of pertussis toxin on epitope recognition by murine monoclonal antibodies.
    Ibsen PH
    Vaccine; 1996 Apr; 14(5):359-68. PubMed ID: 8735545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular pertussis vaccine containing a Bordetella pertussis strain that produces a nontoxic pertussis toxin molecule.
    Marsili I; Pizza M; Giovannoni F; Volpini G; Bartalini M; Olivieri R; Rappuoli R; Nencioni L
    Infect Immun; 1992 Mar; 60(3):1150-5. PubMed ID: 1541530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress towards the development of new vaccines against whooping cough.
    Rappuoli R; Podda A; Pizza M; Covacci A; Bartoloni A; de Magistris MT; Nencioni L
    Vaccine; 1992; 10(14):1027-32. PubMed ID: 1471424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant Mycobacterium bovis BCG expressing pertussis toxin subunit S1 induces protection against an intracerebral challenge with live Bordetella pertussis in mice.
    Nascimento IP; Dias WO; Mazzantini RP; Miyaji EN; Gamberini M; Quintilio W; Gebara VC; Cardoso DF; Ho PL; Raw I; Winter N; Gicquel B; Rappuoli R; Leite LC
    Infect Immun; 2000 Sep; 68(9):4877-83. PubMed ID: 10948100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective activities in mice of monoclonal antibodies against pertussis toxin.
    Sato H; Sato Y
    Infect Immun; 1990 Oct; 58(10):3369-74. PubMed ID: 1698179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralizing antibodies and immunoprotection against pertussis and tetanus obtained by use of a recombinant pertussis toxin-tetanus toxin fusion protein.
    Boucher P; Sato H; Sato Y; Locht C
    Infect Immun; 1994 Feb; 62(2):449-56. PubMed ID: 7507893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of a diphtheria toxin A fragment-C180 peptide fusion protein which elicits a neutralizing antibody response against diphtheria toxin and pertussis toxin.
    Barbieri JT; Armellini D; Molkentin J; Rappuoli R
    Infect Immun; 1992 Dec; 60(12):5071-7. PubMed ID: 1452339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A quantitative analysis for the ADP-ribosylation activity of pertussis toxin: an enzymatic-HPLC coupled assay applicable to formulated whole cell and acellular pertussis vaccine products.
    Cyr T; Menzies AJ; Calver J; Whitehouse LW
    Biologicals; 2001 Jun; 29(2):81-95. PubMed ID: 11580213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between structure and biological and protective activities of pertussis toxin.
    Sato H; Sato Y
    Dev Biol Stand; 1991; 73():121-32. PubMed ID: 1723387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modifications of the catalytic and binding subunits of pertussis toxin by formaldehyde: effects on toxicity and immunogenicity.
    Fowler S; Xing DK; Bolgiano B; Yuen CT; Corbel MJ
    Vaccine; 2003 Jun; 21(19-20):2329-37. PubMed ID: 12744863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of genetically inactivated pertussis toxin mutants: candidates for a new vaccine against whooping cough.
    Nencioni L; Pizza M; Bugnoli M; De Magistris T; Di Tommaso A; Giovannoni F; Manetti R; Marsili I; Matteucci G; Nucci D
    Infect Immun; 1990 May; 58(5):1308-15. PubMed ID: 2323818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acellular pertussis vaccine composed of genetically inactivated pertussis toxin: safety and immunogenicity in 12- to 24- and 2- to 4-month-old children.
    Podda A; De Luca EC; Titone L; Casadei AM; Cascio A; Peppoloni S; Volpini G; Marsili I; Nencioni L; Rappuoli R
    J Pediatr; 1992 May; 120(5):680-5. PubMed ID: 1578301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of pertussis toxin analogs containing mutations in B-oligomer subunits.
    Loosmore S; Zealey G; Cockle S; Boux H; Chong P; Yacoob R; Klein M
    Infect Immun; 1993 Jun; 61(6):2316-24. PubMed ID: 8500874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope specificity of three anti-pertussis toxin monoclonal antibodies with dissimilar effects in assays of toxin neutralizing activity.
    Halperin SA; Issekutz TB; Kasina A
    Mol Immunol; 1991 Mar; 28(3):247-50. PubMed ID: 1708105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.